(株)ケイファーマの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4896/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2025/06/13 | 日証協 | 773,200株 | +4.16% | 190,300株 | +11.35% | 622,765株 | +4.76% | 99,710株 | +35.48% |
| 2025/06/06 | 日証協 | 742,300株 | +3.2% | 170,900株 | +85.36% | 594,455株 | +2.91% | 73,600株 | +45.73% |
| 2025/05/30 | 日証協 | 719,300株 | -10.17% | 92,200株 | -50.67% | 577,655株 | -1.56% | 50,505株 | -28.62% |
| 2025/05/23 | 日証協 | 800,700株 | +10.99% | 186,900株 | +27.75% | 586,790株 | +5.23% | 70,751株 | +48.82% |
| 2025/05/16 | 日証協 | 721,400株 | +8.76% | 146,300株 | +3.25% | 557,644株 | +5.81% | 47,540株 | -35.76% |
| 2025/05/09 | 日証協 | 663,300株 | +11.8% | 141,700株 | +21.94% | 527,043株 | +8.57% | 74,002株 | -23.08% |
| 2025/05/02 | 日証協 | 593,300株 | +4.92% | 116,200株 | -61.56% | 485,442株 | +1.19% | 96,202株 | -57.02% |
| 2025/04/25 | 日証協 | 565,500株 | +46.02% | 302,300株 | -29.09% | 479,738株 | +36.59% | 223,806株 | -15.48% |
| 2025/04/18 | 日証協 | 387,279株 | +150.02% | 426,300株 | +302.25% | 351,230株 | +68.19% | 264,788株 | +105.08% |
| 2025/04/11 | 日証協 | 154,900株 | -84.66% | 105,979株 | -93.6% | 208,825株 | -68.04% | 129,113株 | -72.34% |
| 2025/04/04 | 日証協 | 1,009,900株 | +648.63% | 1,655,700株 | +807.73% | 653,433株 | +289.31% | 466,837株 | +205.12% |
| 2025/03/28 | 日証協 | 134,900株 | +113.79% | 182,400株 | 0% | 167,846株 | +23.92% | 153,003株 | +8900.18% |
| 2025/03/21 | 日証協 | 63,100株 | -2.77% | 0株 | -100% | 135,443株 | -1.17% | 1,700株 | +142.86% |
| 2025/03/14 | 日証協 | 64,900株 | -1.52% | 100株 | -97.3% | 137,043株 | -0.58% | 700株 | +600% |
| 2025/03/07 | 日証協 | 65,900株 | +4.11% | 3,700株 | +8.82% | 137,843株 | +0.22% | 100株 | -96.15% |
| 2025/02/28 | 日証協 | 63,300株 | +5.68% | 3,400株 | 0% | 137,543株 | +1.1% | 2,600株 | +136.36% |
| 2025/02/21 | 日証協 | 59,900株 | 0% | 0株 | 0% | 136,043株 | -0.66% | 1,100株 | +175% |
| 2025/02/14 | 日証協 | 59,900株 | 0% | 0株 | -100% | 136,943株 | -1.44% | 400株 | -87.88% |
| 2025/02/07 | 日証協 | 59,900株 | -2.92% | 3,600株 | 0% | 138,943株 | +0.29% | 3,300株 | +3200% |
※株式分割は考慮していませんのでご注意ください。
Page Top